Cannabis Rescheduling: Page 3

DEA Approves Marion McNabb as Expert Witness for Cannabis Rescheduling Hearing

The doctor in public health will testify as a proponent for reclassifying cannabis to a Schedule III drug under the Controlled Substances Act.

Top 10 Articles of 2024: Farm Bill, Ohio Legalization, Rescheduling Lead CBT’s Coverage

Here’s a roundup of Cannabis Business Times’ most-viewed stories that readers did not want to miss out on from the past year.

Bat Poop Fatalities, Farm Bill Extension Lead CBT’s Top Stories in December

Illinois legislation to regulate hemp products, the DEA’s subpoena blunder and Minnesota’s unknown launch were among the most-read articles this month.

Judge Calls DEA Subpoena Request ‘Blunder,’ Rejects 3 of 4 for Cannabis Rescheduling Hearing

Administrative Law Judge John Mulrooney points out the DEA’s error yet provides the agency another shot at subpoenaing three FDA officials.

The November Election Is Behind Us: Where Are We Now on Cannabis Legalization—Across the States And by the Feds?

Three of four states rejected legalization measures, and federal rescheduling remains uncertain by the Drug Enforcement Administration.

Attorney General Undelegated DEA’s Rescheduling Authority, Lawyers Argue; Possible Stay Could Delay Hearings

The cannabis rescheduling buck stops with the DOJ head, according to attorneys arguing that the DEA administrator cannot issue the final rule.

Cannabis Rescheduling Hearing to Run Through March 2025

A Prehearing Ruling following this week’s preliminary hearing outlines the upcoming schedule and procedures, states the 43,564 public comments submitted ‘unlikely’ to be received into the hearing record.

DEA Counsel Dodges Question on Support for Cannabis Rescheduling

An administrative law judge asked the agency’s lead attorney the question during preliminary proceedings for an upcoming rescheduling hearing.

DEA Could Subpoena HHS in Cannabis Rescheduling Hearings

The Drug Enforcement Administration indicated it could target a ‘novel’ two-factor test used to determine currently accepted medical use.

Smart Approaches to Marijuana Responds to Claims It Colluded With DEA

The prohibitionist group says cannabis rescheduling advocates are attempting to ‘create a sideshow’ of the DEA’s hearing process.

DEA Denies Collusion Allegations Ahead of Cannabis Rescheduling Hearing

The DEA argues that cannabis advocates have no evidence that the agency engaged in unlawful communications with a prohibitionist group.

Cannabis Rescheduling Judge Says Hands Tied Behind Back, Can’t Add More Participants

The DEA’s administrative law judge said he was 'not involved in or apprised of' the process the agency utilized to select the participants.

Previous Page

Page 3 of 12

Next Page